CVM
Price
$8.20
Change
+$1.35 (+19.71%)
Updated
Jul 25 closing price
Capitalization
42.11M
NRXS
Price
$2.77
Change
+$0.01 (+0.36%)
Updated
Jul 25 closing price
Capitalization
26.39M
53 days until earnings call
Interact to see
Advertisement

CVM vs NRXS

Header iconCVM vs NRXS Comparison
Open Charts CVM vs NRXSBanner chart's image
Cel-Sci
Price$8.20
Change+$1.35 (+19.71%)
Volume$945.62K
Capitalization42.11M
Neuraxis
Price$2.77
Change+$0.01 (+0.36%)
Volume$23.39K
Capitalization26.39M
CVM vs NRXS Comparison Chart in %
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVM vs. NRXS commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Buy and NRXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (CVM: $8.20 vs. NRXS: $2.77)
Brand notoriety: CVM: Notable vs. NRXS: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 91% vs. NRXS: 10%
Market capitalization -- CVM: $42.11M vs. NRXS: $26.39M
CVM [@Biotechnology] is valued at $42.11M. NRXS’s [@Biotechnology] market capitalization is $26.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, CVM is a better buy in the long-term than NRXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 5 TA indicator(s) are bullish while NRXS’s TA Score has 6 bullish TA indicator(s).

  • CVM’s TA Score: 5 bullish, 4 bearish.
  • NRXS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than CVM.

Price Growth

CVM (@Biotechnology) experienced а +107.07% price change this week, while NRXS (@Biotechnology) price change was +5.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

NRXS is expected to report earnings on Sep 18, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVM($42.1M) has a higher market cap than NRXS($26.4M). NRXS YTD gains are higher at: 17.872 vs. CVM (-31.650). NRXS has higher annual earnings (EBITDA): -8.11M vs. CVM (-21.96M). NRXS (2.01M) and CVM (1.92M) have equal amount of cash in the bank . NRXS has less debt than CVM: NRXS (389K) vs CVM (10.5M). NRXS has higher revenues than CVM: NRXS (2.94M) vs CVM (0).
CVMNRXSCVM / NRXS
Capitalization42.1M26.4M159%
EBITDA-21.96M-8.11M271%
Gain YTD-31.65017.872-177%
P/E RatioN/AN/A-
Revenue02.94M-
Total Cash1.92M2.01M96%
Total Debt10.5M389K2,699%
FUNDAMENTALS RATINGS
CVM: Fundamental Ratings
CVM
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVMNRXS
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMSI0.790.04
+5.03%
Smith Micro Software
ACEL12.740.31
+2.49%
Accel Entertainment
SIG84.761.16
+1.39%
Signet Jewelers Limited
TGT106.050.23
+0.22%
Target Corp
III4.53-0.02
-0.44%
Information Services Group

CVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
+19.71%
NRXS - CVM
59%
Loosely correlated
+0.36%
EYPT - CVM
37%
Loosely correlated
-0.10%
MGX - CVM
33%
Poorly correlated
-3.19%
DTIL - CVM
29%
Poorly correlated
+3.00%
ATHE - CVM
28%
Poorly correlated
+15.32%
More

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+0.36%
CVM - NRXS
59%
Loosely correlated
+19.71%
BTAI - NRXS
27%
Poorly correlated
+4.62%
CTMX - NRXS
25%
Poorly correlated
+0.42%
TSHA - NRXS
23%
Poorly correlated
+2.32%
MRVI - NRXS
23%
Poorly correlated
-0.74%
More